News | News By Subject | News by Disease News By Date | Search News

Approvals News

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Merck & Co. (MRK)'s Immuno-Oncology Star Racks Up Two New Bladder Cancer Approvals     5/19/2017
Mitsubishi Tanabe Wins FDA Approval for Radicava, the First New ALS Drug in 22 Years     5/8/2017
AstraZeneca PLC (AZN) Hits Milestone With Approval of Potential Bladder Cancer Blockbuster     5/3/2017
Wowsers! FDA Approves BioMarin (BMRN)'s Brineura, the First Drug for Batten Disease     5/2/2017
Takeda (TKPYY)'s $5 Billion Bet on Ariad (ARIA) Pays Off With Accelerated Approval of Lung Cancer Med     5/1/2017
Nothing's Gonna Stop Neurocrine Biosciences (NBIX) Now: Shares Jumped on FDA Approval of the First and Only Drug to Treat Tardive Dyskinesia for Adults     4/13/2017
FDA Finally Allows 23andMe to Sell At-Home DNA Tests for 10 Diseases     4/10/2017
What a Day! Genentech (RHHBY) Lands FDA Approval for First Drug to Treat Severe Multiple Sclerosis     4/4/2017
Teva (TEVA) Finally Wins FDA Approval for Potential Huntington’s Blockbuster Austedo     4/4/2017
FDA Clears Massachusetts Biotech Tesaro (TSRO)'s Ovarian Cancer PARP Inhibitor     3/29/2017
Sarepta (SRPT) Under Pressure As Marathon Pharma Emflaza's Wins FDA Approval for DMD     2/13/2017
FDA Approval of Aurobindo (AUROPHARMA.BO)'s Two Drugs Sends Stock Up     1/3/2017
FDA Approves First-Ever Treatment for Spinal Muscular Atrophy; Ionis Pharma (IONS), Biogen (BIIB) Seal Victory     12/29/2016
This Is Why Woodcock OKed Sarepta (SRPT)'s DMD Drug     11/4/2016
Sarepta (SRPT) Gets No Love From the FDA's New Drugs Director     10/21/2016

Featured Stories
Faster FDA Approvals? Not So Fast: 1 Out of 3 New Drugs Had Safety Problems No One Knew About     5/10/2017
Why Newron Pharma (NWRN)'s Newly Approved Parkinson's Drug Isn't All That Novel     3/23/2017
Genentech (RHHBY)’s Tecentriq Wins Second Approval of the Year, This Time for Lung Cancer     10/19/2016
Approving A Muscular Dystrophy Drug Exposes A Civil War At The FDA     9/20/2016
FDA Delays: Hurry Up and Wait     9/23/2008
FDA On Pace To Approve 18 New Drugs In 2008     8/8/2008
FDA Approves 2008-2009 Season's Flu Vaccines: CSL Limited (CMXHF.PK), Afluria. GlaxoSmithKline Biologicals (GSK), Fluarix. ID Biomedical Corporation (IDBE) of Quebec, FluLaval. MedImmune Vaccines, FluMist. Novartis Vaccines & Diagnostics, Inc. (NVS), Fluvirin. Sanofi Pasteur (SASY.PA), Fluzone.     8/6/2008
Drugmakers Agree to Wait on Advertising New Drugs; Congressional Hearing Focused on Pfizer Inc. (PFE)'s Lipitor, Johnson & Johnson (JNJ)'s Procrit, and Vytorin Sold by Merck & Co., Inc. (MRK) and Schering-Plough Pharmaceuticals     6/18/2008
Simcere Pharmaceutical Group Given SFDA Approval for Generic Antibiotic     5/14/2008
China Biologic Products Reports Two SFDA Successes     5/1/2008
Pharmaceutical Safety: If A Drug Has FDA's OK, Should You Be Able To Sue? -- Editorial, Opinion Piece     4/28/2008
Sinovac Biotech Ltd. (SNVBF) Granted SFDA Approval for Avian Flu Vaccine     4/2/2008
Oculus Innovative Sciences, Inc. (OCLS) Announces SFDA Approval of Microcyn     3/31/2008
Study Shows FDA Deadlines Affect Drug Safety     3/27/2008
Tianyin Pharmaceutical Co, Inc. Wins SFDA Approval for Antibiotic     3/17/2008
Second Drug Receives FDA Approval For Bladder Cancer Based On Research Led By NYU Langone Medical Center     5/22/2017
FDA Green Lights Genentech (RHHBY)’s Actemra for Giant Cell Arteritis     5/22/2017
Immune Therapeutics Announces NAFDAC Approval For Marketing And Distribution Of Lodonal     5/22/2017
Cook Medical Wins FDA Approval for Device to Treat Rare Birth Defect     5/22/2017
FDA Clears Soterix Medical's IontoDC System     5/22/2017
Swedish Orphan AB - Elocta Approved In The Kingdom Of Saudi Arabia For The Treatment Of Haemophilia A     5/18/2017
Vertex (VRTX) Release: FDA Approves KALYDECO (Ivacaftor) For More Than 900 People Ages 2 And Older With Cystic Fibrosis Who Have Certain Residual Function Mutations     5/18/2017
Bay Area's MyoScience Wins FDA Nod for Iovera Knee Osteoarthritis Device     5/18/2017
Abon Pharmaceuticals Received Approval from the U.S. FDA for Clofarabine Injection     5/17/2017
Bristol-Myers Squibb Canada Release: Health Canada Approves OPDIVO (Nivolumab) For The Treatment Of Squamous Cell Carcinoma Of The Head And Neck     5/17/2017
Swedish Orphan Biovitrum - Orfadin Capsules Approved In The Kingdom Of Saudi Arabia For The Treatment Of Hereditary Tyrosinemia Type 1     5/17/2017
Dr. Reddy's Laboratories Ltd. (RDY) Announces FDA Approval For The Launch Of Doxorubicin Hydrochloride Liposome Injection In The U.S. Market     5/17/2017
Sweden's BrainCool Enters U.S. Market With FDA 510(k) Clearance for IQool System for Temperature Management     5/17/2017
Pharmadax Receives FDA Approval For A Generic Version Of Seroquel XR     5/16/2017
Lannett (LCI) Announces Approval For Levocetirizine Dihydrochloride Oral Solution, 2.5 mg/5 mL (0.5 mg/mL)     5/16/2017

More News
No News Posted on that date

Career Tips
Size Matters: Why a Biotech's Size Can Affect Your Career     5/12/2017
Interview Insider: Tips on How to Get Hired at Johnson & Johnson (JNJ), Bristol-Myers Squibb (BMY), and Novartis AG (NVS)     5/12/2017
Top 5 Jobs for Introverted Life Scientists     5/12/2017
What It's Like To Work For Drug Giant Sanofi (SNY)     5/11/2017
The Tide Is Turning For Biomedical Sciences Training     5/11/2017
How Scientists Can Transition Into A Non-Research Career     5/11/2017
Sweet Revenge: Job Prospects Great For Science Geeks And Nerds     5/11/2017
How To Resign From Your Life Sciences Job     5/11/2017
5 Steps to Prep Your Resume for a Career Event     5/8/2017
How to Prepare for a Talent Connect Career Event     5/1/2017
This Is By Far the #1 Highest Paying Non-Executive Biotech Job in the U.S.     5/1/2017
Top 10 R&D Scientist Skills in Demand     5/1/2017
The Biotech Job Title You've Probably Never Heard Of     5/1/2017
Do Aging Scientists Limit Job Opportunities For Young Researchers?     4/22/2017
How Using Recruiters Can Benefit Your Life Science Job Search     4/22/2017

Other News Sources
//-->